SCHEMBL890314

SCHEMBL890314

OCC1OC2OC2C(O)C1O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.67
TSHR P16473 2/20 0.67
LMNA P02545 1/20 0.67
TDP1 Q9NUW8 1/20 0.67
TXNRD1 Q16881 6/20 0.59
TXNRD3 Q86VQ6 6/20 0.59
TXNRD2 Q9NNW7 6/20 0.59
LGALS1 P09382 2/20 0.46
LGALS3 P17931 2/20 0.46
LGALS9 O00182 1/20 0.46
LGALS8 O00214 1/20 0.46
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
CA12 O43570 3/20 0.37
CA1 P00915 3/20 0.37
CA2 P00918 3/20 0.37
CA9 Q16790 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4911677 1.00 ALDH1A1 (0.67) ALDH1A1TSHRLMNATDP1TXNRD1
SCHEMBL6266510 1.00 ALDH1A1 (0.67) ALDH1A1TSHRLMNATDP1TXNRD1
SCHEMBL28471882 1.00 ALDH1A1 (0.67) ALDH1A1TSHRLMNATDP1TXNRD1
SCHEMBL1193222 1.00 ALDH1A1 (0.67) ALDH1A1TSHRLMNATDP1TXNRD1
SCHEMBL18736267 1.00 ALDH1A1 (0.67) ALDH1A1TSHRLMNATDP1TXNRD1
SCHEMBL16016300 1.00 ALDH1A1 (0.67) ALDH1A1TSHRLMNATDP1TXNRD1
SCHEMBL6450045 1.00 ALDH1A1 (0.67) ALDH1A1TSHRLMNATDP1TXNRD1
SCHEMBL4911680 1.00 ALDH1A1 (0.67) ALDH1A1TSHRLMNATDP1TXNRD1
SCHEMBL4911675 1.00 ALDH1A1 (0.67) ALDH1A1TSHRLMNATDP1TXNRD1
SCHEMBL4070795 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023094699-A1 INHIBITORS OF ABNORMAL PHOSPHORYLATION AND TAU PROTEIN AGGREGATION UNIVERSITE DE PICARDIE JULES VERNE (FR) 2023-06-01 WO disclosed
US-20180105547-A1 METHODS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES CHILDREN'S MEDICAL CENTER CORPORATION (US) 2018-04-19 US disclosed
US-20170274377-A1 MICRO NANOPOROUS MEMBRANE, PREPARING METHOD THEREOF AND MICROFLUIDIC DEVICE USING THEREOF THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC) (KR) 2017-09-28 US disclosed
US-20120301535-A1 COMBINATION PEPTIDE-NANOPARTICLES AND DELIVERY SYSTEMS INCORPORATING SAME AQUESTIVE THERAPEUTICS, INC. 2012-11-29 US disclosed
US-20120009260-A1 NANOPARTICLE FILM DELIVERY SYSTEMS AQUESTIVE THERAPEUTICS, INC. 2012-01-12 US disclosed
US-7834159-B2 Pharmacokinetics; glycosyltransferases; vaccines THE SCRIPPS RESEARCH INSTITUTE (US) 2010-11-16 US disclosed
US-7772380-B2 Ceramide derivatives as modulators of immunity and autoimmunity ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2010-08-10 US disclosed
WO-2010081026-A1 BACTERIAL VACCINES WITH CELL WALL-ASSOCIATED CERAMIDE-LIKE GLYCOLIPIDS AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY, A DIVISION OF YESHIVA UNIVERSITY (US) 2010-07-15 WO disclosed
US-20070238673-A1 Ceramide derivatives as modulators of immunity and autoimmunity ALBERT EINSTEIN COLLEGE OF MEDICINE 2007-10-11 US disclosed
US-20070172915-A1 Glycoprotein synthesis THE SCRIPPS RESEARCH INSTITUTE (US) 2007-07-26 US disclosed
US-7217809-B2 Glycoprotein synthesis THE SCRIPPS RESEARCH INSTITUTE (US) 2007-05-15 US disclosed
US-7183082-B2 Glycoprotein synthesis THE SCRIPPS RESEARCH INSTITUTE (US) 2007-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180105547-A1 METHODS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES ICOS, HRH2, HRH4 ALDH1A1 915/4885TSHR 1570/4885LMNA 4647/4885
US-20070238673-A1 Ceramide derivatives as modulators of immunity and autoimmunity CERS2, UGCG, SGMS1 ALDH1A1 4340/4885TSHR 2845/4885LMNA 2169/4885
US-20120009260-A1 NANOPARTICLE FILM DELIVERY SYSTEMS CD63, DSTN, EPCAM ALDH1A1 994/4885TSHR 2655/4885LMNA 1110/4885
US-20120301535-A1 COMBINATION PEPTIDE-NANOPARTICLES AND DELIVERY SYSTEMS INCORPORATING SAME CALCA, LNPEP, IAPP ALDH1A1 4292/4885TSHR 757/4885LMNA 1440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.